BioInvent International
BioInvent: Good Safety Profile for BT-001 (Redeye)
2022-06-27 13:03
Redeye makes an adjustment to the project’s LOA based on results from BT-001’s phase I trial, part A.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se